“Proteins that are engineered in the laboratory for pharmaceutical use are referred to as therapeutic proteins”.
Protein-based therapeutics are highly successful in clinic and currently enjoy unprecedented recognition of their potential.
Recently approved recombinant protein therapeutics have been developed to treat a wide variety of clinical indications, including cancers, autoimmunity/inflammation, exposure to infectious agents, and genetic disorders.
Over the past 10 years, Creative BioMart has become a leader in discovery and manufacturing of recombinant proteins, providing quality products and services to our customers for both academic and industrial field.